Cognitive Enhancers for Alzheimer’s Dementia (using Individual Patient Data)

Home Cognitive Enhancers for Alzheimer’s Dementia (using Individual Patient Data)

    Comparative safety and effectiveness of cognitive enhancers for Alzheimer’s dementia: a systematic review and individual patient data network meta-analysis (IPD-NMA)

     

    Commissioned and Funded by: Canadian Institutes of Health Research (CIHR) through the Drug Safety and Effectiveness Network (DSEN)

     

    Share Buttons

    [ssba-buttons]
    • Aims to examine the comparative effectiveness and safety of cognitive enhancers versus placebo or best supportive care by patient characteristics, such as Alzheimer’s dementia severity and sex
    • The outputs of this study will provide clinicians, patients and caregivers with tailored evidence to inform their decision-making

     

    Category :

    Date : 21 Aug 2020

    Copyright © 2019 Knowledge Translation Program